Ultralife Corporation (ULBI)

Ultralife Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	168.66	158.64	131.84	98.27	107.71	106.8
Revenue Growth (YoY)	26.44%	20.33%	34.17%	-8.77%	0.86%	22.49%
Cost of Revenue	125.42	119.44	102.44	73.63	78.55	75.63
Gross Profit	43.23	39.2	29.4	24.64	29.16	31.17
Selling, General & Admin	22.47	22.19	22.19	17.78	17.51	16.99
Research & Development	7.26	7.53	7.08	6.83	5.95	6.81
Operating Expenses	29.72	29.73	29.27	24.61	23.46	23.8
Operating Income	13.51	9.48	0.13	0.04	5.7	7.37
Interest Expense / Income	2.11	2.02	0.95	0.24	0.44	0.54
Other Expense / Income	-1.82	-1.69	-0.38	-0.05	-1.66	0.17
Pretax Income	13.22	9.15	-0.45	-0.16	6.92	6.66
Income Tax	2.79	1.95	-0.33	0.08	1.69	1.46
Net Income	10.43	7.2	-0.12	-0.23	5.23	5.21
Net Income Growth	-	-	-	-	0.52%	-79.12%
Shares Outstanding (Basic)	16	16	16	16	16	16
Shares Outstanding (Diluted)	17	16	16	16	16	16
Shares Change	2.37%	0.63%	0.55%	-0.37%	-0.51%	-1.03%
EPS (Basic)	0.64	0.44	-0.01	-0.01	0.33	0.33
EPS (Diluted)	0.64	0.44	-0.01	-0.01	0.33	0.32
EPS Growth	-	-	-	-	3.13%	-79.08%
Free Cash Flow	0.79	-0.62	-2.94	1.51	18.74	-9.25
Free Cash Flow Per Share	0.05	-0.04	-0.18	0.09	1.18	-0.59
Gross Margin	25.63%	24.71%	22.30%	25.08%	27.07%	29.18%
Operating Margin	8.01%	5.97%	0.10%	0.04%	5.29%	6.90%
Profit Margin	6.19%	4.54%	-0.09%	-0.24%	4.86%	4.87%
Free Cash Flow Margin	0.47%	-0.39%	-2.23%	1.54%	17.40%	-8.66%
Effective Tax Rate	21.08%	21.33%	-	-	24.44%	21.87%
EBITDA	19.24	15.08	4.97	3.63	10.3	9.95
EBITDA Margin	11.41%	9.50%	3.77%	3.69%	9.56%	9.31%
Depreciation & Amortization	3.91	3.91	4.46	3.54	2.94	2.75
EBIT	15.33	11.16	0.51	0.09	7.36	7.2
EBIT Margin	9.09%	7.04%	0.38%	0.09%	6.83%	6.74%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).